Detection of atovaquone and Malarone™ resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb)
- 1 April 2003
- journal article
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 17 (2-3) , 85-89
- https://doi.org/10.1016/s0890-8508(03)00006-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reportsBMJ, 2003
- Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, NigeriaMalaria Journal, 2002
- Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind studyThe Lancet, 2000
- Atovaquone resistance in malaria parasitesDrug Resistance Updates, 2000
- Mutations in Plasmodium falciparum Cytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding SiteAntimicrobial Agents and Chemotherapy, 2000
- A Mechanism for the Synergistic Antimalarial Action of Atovaquone and ProguanilAntimicrobial Agents and Chemotherapy, 1999
- Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.The American Journal of Tropical Medicine and Hygiene, 1999
- Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial ParasiteJournal of Biological Chemistry, 1997
- Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malariaJournal of Antimicrobial Chemotherapy, 1995
- Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activityParasitology, 1985